Short answer · Medically reviewed summary · Last updated: 2026-05-08
Erythema Multiforme was first described in 1866 by Ferdinand von Hebra, who characterized its distinct "target" or "iris" lesions. Over the last 150 years, the understanding of Erythema Multiforme has shifted from a broad, poorly defined dermatological eruption to a well-understood hypersensitivity reaction, most commonly triggered by the Herpes Simplex Virus (HSV). Who first identified Erythema Multiforme? The history of Erythema Multiforme begins with the Austrian dermatologist Ferdinand von Hebra.
1 people with Erythema Multiforme have shared their first-person experience on this question at DiseaseMaps.
Erythema Multiforme was first described in 1866 by Ferdinand von Hebra, who characterized its distinct "target" or "iris" lesions. Over the last 150 years, the understanding of Erythema Multiforme has shifted from a broad, poorly defined dermatological eruption to a well-understood hypersensitivity reaction, most commonly triggered by the Herpes Simplex Virus (HSV).
The history of Erythema Multiforme begins with the Austrian dermatologist Ferdinand von Hebra. In 1866, he coined the term "erythema multiforme exudativum" to describe the polymorphous nature of the skin lesions. He observed that patients presented with a variety of shapes—ranging from papules to vesicles—that often formed concentric, ring-like patterns.
Historically, Erythema Multiforme was often conflated with more severe conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). It took decades of clinical observation to distinguish these entities. We now know that while SJS/TEN is typically triggered by medications, Erythema Multiforme is predominantly an immune-mediated response to infections, particularly the Herpes Simplex Virus.
Modern clinical research has refined the management of the condition through several key milestones:
For the 42 people with Erythema Multiforme currently on DiseaseMaps.org, the shift toward patient-centered advocacy has been vital. Historically, patients were often misdiagnosed or dismissed. Today, collaborative platforms allow patients to share experiences, leading to better awareness of the triggers, such as HSV or mycoplasma pneumoniae, and improving the speed of diagnosis.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.